FDA Revises Its Letter for Non Approval of Drugs
New York Times 2008 July 10; p. C9
Showing items related by title, author, creator and subject.
CETUS Commentaries (FDA Members' Letter Regarding Policy on the Safety Approval of Recombinant DNA Proteins and Drugs) LaMonica, Filippo; Woodcock, Janet; Siegel, Jay P.; Zoon, Kathryn C.; Miller, Henry I. (1991-02)
Prescription Drugs: Many Factors Affects FDA's Approval of Selected "Pipeline" Drugs. Report to Congressional Requesters Unknown author (United States. General Accounting Office [GAO], 2000-08)
Hansen, Robert W.; Ranelli, Paul L.; Ried, L. Douglas (1995)